News

/
/
/
Relative Effectiveness Assessment of Pharmaceuticals: A EUnetHTA Joint Action Initiative

Relative Effectiveness Assessment of Pharmaceuticals: A EUnetHTA Joint Action Initiative

In 2010, the ISPOR Annual European Congress had HTA as its main theme. EUnetHTA and its activities were in focus both at the Plenary Sessions and numerous educational symposia, workshops and issue panels. Through the links below you will be able to access the presentations covering EUnetHTA activities or topics of interest/collaboration within EUnetHTA.

Presentation for the ISPOR Prague Plenary Session:

Relative Effectiveness Assessment of Pharmaceuticals: A EUnetHTA Joint Action Initiative
Wim Goettsch PhD
Deputy Secretary of the Medicinal Products Reimbursement Committee, Health Care Insurance Board (CVZ) and European network for Health Technology Assessment (EUnetHTA) Partner, Diemen, The Netherlands

Relative Effectiveness Assessment of Pharmaceuticals A EUnetHTA Joint Action Initiative

This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.